ALXOALX Oncology Holdings Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 11629
Ticker: ALXO
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2020-07-17
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: ALXO

Detail

Enriched 2026-08-14 20:47

Market cap: $277,936,763.97
Shares outstanding (class): 138,276,997
Shares outstanding (weighted): 138,276,997
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 48
Location: SOUTH SAN FRANCISCO, CA
Homepage: https://www.alxoncology.com
Description: ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. It is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.

Market cap and share counts drift.

Funds holding this security

9 funds · 9 positions · $8.60M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$7.30M	0.00%	3,642,854 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$803.4K	0.00%	400,719 NS	FIGI
VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX… VANGUARD INSTITUTIONAL INDEX FUNDS	—	$145.4K	0.00%	72,511 NS	FIGI
VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS	—	$127.6K	0.00%	63,652 NS	FIGI
Ultra-Small Company Market Fund Bridgeway Funds, Inc.	—	$122.3K	0.10%	61,000 NS	FIGI
Small Cap Core Fund Northern Funds	—	$35.2K	0.01%	17,558 NS	FIGI
Ultra-Small Company Fund Bridgeway Funds, Inc.	—	$30.2K	0.04%	15,072 NS	FIGI
Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds	—	$21.9K	0.00%	10,900 NS	FIGI
Diversified Equity Master Portfolio Master Investment Portfolio	—	$9.7K	0.00%	4,859 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERALXO
FIGI_COMPOSITEBBG00VR8SDG8
FIGI_SHARE_CLASSBBG00VR8SF73
CIK0001810182
ISINUS00166B1052
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Biotechnology
Source: LLMunreviewed
Self-reported confidence: 0.9
Model: deepseek
Rationale: ALX Oncology is a clinical-stage biopharmaceutical company focused on cancer therapies, fitting the biotechnology industry.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.